Filters close
Released: 24-Apr-2024 1:30 PM EDT
ADLM announces 2024 award winners; celebrates achievements in laboratory medicine
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is proud to announce the recipients of the 2024 ADLM and Academy of Diagnostics & Laboratory Medicine Awards. Through this annual awards program, ADLM and its Academy recognize individuals around the world for outstanding research and service in the field of laboratory medicine and highlight the vital contributions made by all lab professionals to patient care.

Released: 9-Apr-2024 9:25 AM EDT
Association for Diagnostics & Laboratory Medicine (formerly AACC) survey of clinical labs finds that FDA’s proposed laboratory developed tests rule would hinder pediatric care
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

Today, the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) released the results of a survey the organization conducted to determine how the Food and Drug Administration’s (FDA’s) proposed laboratory developed tests rule would impact patient care.

Released: 21-Mar-2024 9:05 AM EDT
Association for Diagnostics & Laboratory Medicine (formerly AACC) Submits Testimony to Congress Opposing FDA’s Proposed LDTs Rule
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

“Today, we at the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) provided testimony to Congress regarding the impact of the Food and Drug Administration’s (FDA’s) proposed rule to impose FDA oversight on laboratory developed tests in addition to Centers for Medicare & Medicaid Services (CMS) oversight. While we share FDA’s goal of ensuring that laboratory developed tests are safe and effective, we have serious concerns about the agency’s proposal. If finalized, this rule would create a burdensome dual regulatory structure that would limit patient access to many life-saving tests.

Released: 14-Mar-2024 1:15 PM EDT
New Tuberculosis Test Could Improve TB Care Globally by Increasing Access to Testing in Low- and Middle-Income Countries
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

A new tuberculosis (TB) test disclosed in the Association for Diagnostics & Laboratory Medicine’s (formerly AACC’s) Clinical Chemistry journal would allow testing for TB treatment monitoring to occur outside of a biosafety level 3 (BSL-3) laboratory.

Released: 19-Jan-2024 10:20 AM EST
Association for Diagnostics & Laboratory Medicine (formerly AACC) Response to CMS Statement on FDA LDTs Proposed Rule
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

“We at the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) were surprised to see a statement from Drs. Jeff Shuren and Dora Hughes from the Centers for Medicare & Medicaid Services (CMS) in support of the U.S. Food & Drug Administration’s (FDA’s) proposed rule to duplicate the regulation of laboratory developed tests by placing these tests under FDA authority, in addition to their current regulation under CMS.

Released: 4-Jan-2024 2:55 PM EST
Lapatinib Increases Overall Survival in Metastatic Breast Cancer Patients With HER2-Positive Circulating Tumor Cells
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

A new study shows that lapatinib, a drug used for the treatment of metastatic HER2-positive cancer, is associated with improved overall survival in patients with initially HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells (CTCs).

Released: 4-Jan-2024 2:50 PM EST
Advances in Liquid Biopsy That Are Poised to Improve Cancer Care Highlighted in Special Issue of ADLM’s Clinical Chemistry Journal
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

The Association for Diagnostics & Laboratory Medicine’s (formerly AACC’s) Clinical Chemistry journal released a special issue today titled “Cancer: Biology and Diagnostics,” which presents a wide range of discoveries with the potential to improve cancer diagnosis and treatment.

Released: 3-Jan-2024 12:00 PM EST
Molecular Diagnostics Research That Could Transform Healthcare Featured in the January Issue of ADLM’s The Journal of Applied Laboratory Medicine
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

Molecular diagnostics is a powerful branch of laboratory medicine that examines the fundamental genetic and biochemical components of life to provide invaluable insights into health and disease.

Released: 7-Dec-2023 1:30 PM EST
Lessons Learned From ADLM’s COVID Immunity Study Could Improve Research on Future Pandemics
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

A special report published today in the Association for Diagnostics & Laboratory Medicine’s (ADLM’s, formerly AACC’s) The Journal of Applied Laboratory Medicine describes the design, operations, and methodology of the COVID Immunity Study, a large-scale scientific study by ADLM that took place in September 2021.

Released: 30-Oct-2023 1:00 PM EDT
Strategies Behind Near-Zero COVID-19 Incidence in NBA “Bubble” Published in ADLM’s The Journal of Applied Laboratory Medicine
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

A report published today in the Association for Diagnostics & Laboratory Medicine’s (formerly AACC’s) The Journal of Applied Laboratory Medicine describes the strategies used by the National Basketball Association (NBA) to limit COVID-19 exposure among the individuals who participated in the 2019–2020 season. The success of the NBA’s approach demonstrates that strict adherence to certain protocols can be highly effective in preventing disease outbreaks in a self-contained environment and serves as a model for future pandemic management.

Released: 5-Oct-2023 2:20 PM EDT
MEDIA ADVISORY - Briefing: Improving Children’s Health—The Need for Better Pediatric Laboratory Testing
Association for Diagnostics & Laboratory Medicine (ADLM)

Join the Association for Diagnostics & Laboratory Medicine (formerly AACC) and leading experts in laboratory medicine and pediatric health for a discussion about what needs to be done to improve pediatric reference intervals and why this is critical to ensuring that children get effective care.

Newswise: Maritel Dasco Named the Chief Financial Officer of ADLM
Released: 3-Oct-2023 10:45 AM EDT
Maritel Dasco Named the Chief Financial Officer of ADLM
Association for Diagnostics & Laboratory Medicine (ADLM)

The Association for Diagnostics & Laboratory Medicine (ADLM) is pleased to announce that Maritel Dasco assumed the position of chief financial officer (CFO) for the association on September 25.

Released: 30-Sep-2023 1:30 PM EDT
Association for Diagnostics & Laboratory Medicine (formerly AACC) Statement on Proposed FDA Rule on Laboratory Developed Tests
Association for Diagnostics & Laboratory Medicine (ADLM)

We at the Association for Diagnostics & Laboratory Medicine were disappointed to see the U.S. Food & Drug Administration’s (FDA’s) attempt to circumvent Congress with its new proposed rule to duplicate the regulation of laboratory developed tests by placing these tests under FDA authority, in addition to their current regulation under the Centers for Medicare and Medicaid Services.

Released: 29-Aug-2023 2:15 PM EDT
Clinical Labs’ Quick Response to COVID-19 Helped Reduce Hospitalizations and Save Lives
Association for Diagnostics & Laboratory Medicine (ADLM)

A new survey from the Association for Diagnostics & Laboratory Medicine (formerly AACC) found that clinical labs’ robust, rapid response to the COVID-19 pandemic helped to contain the virus and save lives. However, the challenges labs faced with insufficient supplies and staffing shortages have only intensified since 2020. The percentage of laboratory professionals reporting staffing issues rose steadily from 35.4% in May 2020 to 87.5% in January 2022—raising questions about whether labs would have the necessary resources to respond to a similar public health emergency today.

Released: 27-Jul-2023 2:20 PM EDT
Advances in Big Data for Precision Medicine, Novel Technologies to Determine a Pathogen’s Susceptibility to Antibiotics, the Microbiome’s Impact on Childhood Undernutrition, and More Draw Nearly 20,000 Attendees to 2023 AACC Annual Scientific Meeting
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

The Association for Diagnostics and Laboratory Medicine (ADLM), formerly AACC, welcomed thousands of laboratory experts to the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo from July 23-27. At this year’s special meeting celebrating ADLM’s 75th anniversary, the organization officially rolled out a new name that reflects the association’s role as advocate and champion for a larger community specializing in diagnostics and laboratory medicine, as well as its global reach.

Released: 26-Jul-2023 1:10 PM EDT
Revolutionizing Liquid Biopsy: Zymo Research and Opentrons Partner to Automate Novel Cell-Free DNA Isolation Chemistry
2023 AACC Annual Scientific Meeting Press Program

Zymo Research Corp, a leading provider of life science technologies, has partnered with Opentrons Labworks, Inc., a leader in lab automation, to revolutionize cell-free DNA isolation and analysis.

19-Jul-2023 10:00 AM EDT
Breaking Research on Advances in Drug Testing for Marijuana and Fentanyl
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

Two studies featured today at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo highlight advances that could boost the accuracy of marijuana tests and provide vital information for addressing the opioid epidemic.

Newswise: First Ever Point-of-Care Instrument to Test for Fentanyl Receives FDA Clearance
Released: 26-Jul-2023 8:15 AM EDT
First Ever Point-of-Care Instrument to Test for Fentanyl Receives FDA Clearance
2023 AACC Annual Scientific Meeting Press Program

Shenzhen Superbio Technology Co., LTD. (Superbio) has received clearance from the US Food and Drug Administration (FDA) on the first ever point-of-care instrument intended for qualitative detection of fentanyl in human urine and has fully released authorization to Bioeasy USA, Inc.(Bioeasy) of this product in the United States of America.

Newswise: Actiphage TB awarded US Patent grant for diagnostic kit
Released: 25-Jul-2023 10:50 PM EDT
Actiphage TB awarded US Patent grant for diagnostic kit
2023 AACC Annual Scientific Meeting Press Program

PBD Biotech developers of Actiphage TB, a ground-breaking phage-based diagnostic for laboratory tuberculosis testing, has today announced it has secured the grant of a US patent for its diagnostic kit. The company is exhibiting in the AACC Clinical Lab Expo on booth #4578.



close
0.13941